Evaxion Biotech A/S' (EVAX) CEO Lars Wegner on Q1 2022 Results - Earnings Call Transcript

Evaxion Biotech A/S (EVAX) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET

Company Participants

Corey Davis – LifeSci Advisors
Lars Wegner – Chief Executive Officer
Jesper Nyegaard Nissen – Interim Chief Financial Officer

Conference Call Participants

Kevin DeGeeter – Oppenheimer
Ahu Demir – Ladenburg
Thomas Flaten – Lake Street

Operator

Greetings, and welcome to the Evaxion Biotech First Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host Corey Davis of LifeSci Advisors. Please go ahead, sir.

Corey Davis

Thanks, Peter. Hello, everyone, and thanks for joining us. I’d like to remind everyone that the following discussion contains certain statements that are considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Because forward-looking statements involve risks and uncertainties, they are not guarantees of future performance and actual results may differ materially from those expressed or implied by these forward-looking statements due to a variety of factors, including those risk factors discussed in the company’s prospectus filed on November 5, 2021, and the company’s current and future reports filed with or submitted to the Securities and Exchange Commission.

At this time, I’d like to turn the conference call over to Lars Wegner, the company’s President and CEO. Please go ahead, Lars.

Lars Wegner

Thank you, Corey, and good morning to everyone. So thank you for joining us for this Evaxion Biotech’s Q1 earnings call. I'm Lars Wegner, Chief Executive Officer of Evaxion. With me today is Evaxion's Chief Operating Officer, Jesper Nyegaard Nissen, who is currently Interim Chief Financial Officer. We’ll give you a short presentation on our business and results, and then open the call for your questions.